In CKD, elevated serum IL-8 levels correlate with VC severity, driven by hyperphosphatemia-induced endothelial cell (EC) secretion of IL-8, which suppresses osteopontin (OPN) expression in VSMCs and compromises intrinsic anti-calcific defenses (45). Here, CXCL8 is linked to hyperphosphatemia.